GlaxoSmithKline Czech Republic - Deferred Tax Liabilities

GlaxoSmithKline CR`s Deferred Tax Liabilities reached 0.114 CZK mil in 2004. This is the same as in the previous year.

$1.99

Buy Deferred Tax Liabilities data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             0 0 0 0 0    
Bayer Czech Republic CZK mil ... ... ...                 0 0 0 0 0    
GlaxoSmithKline Czech Republic CZK mil ... ... ... ...   ... ... ... ... ... ... ... ... ... ... ... ... ...
Merck Czech Republic CZK mil ... ...                   0 0 0 0 0    
Novartis Czech Republic CZK mil                       0 0 0 0 0    
Pfizer Czech Republic CZK mil ... ...                   0 0 0 0 0    
Roche Czech Republic CZK mil ... ... ...                 1.46 0 0 0 0   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               0 0 0 0 0    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 0 0 0 0    
Walmark CZK mil ... ... ...                 29.0 24.0 4.11 3.95 0